Clinical Trials Logo

Cholecystectomy clinical trials

View clinical trials related to Cholecystectomy.

Filter by:

NCT ID: NCT04622813 Completed - Pain, Postoperative Clinical Trials

Nonopioid Analgesics and Cholecystectomy

Start date: April 8, 2021
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to evaluate the effect of the addition of nefopam to a multimodal analgesic regimen consisting of ketoprofen and paracetamol during sevoflurane- dexmedetomidine-based anesthesia on postoperative morphine requirements in patients undergoing laparoscopic cholecystectomy.

NCT ID: NCT04587973 Completed - Anesthesia Clinical Trials

Bilateral Erector Spinae Plane Block (ESPB) in Laparoscopic Cholecystectomies

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The aim of the trial is to study the efficacy of bilateral Erector Spinae Plane Block (ESPB) in managing perioperative pain in patients who undergo elective laparoscopic cholecystectomy

NCT ID: NCT04551820 Completed - Cholecystectomy Clinical Trials

Study of Peri-operative and Acute Outcomes After Robotic-assisted Cholecystectomy

SPARC
Start date: August 5, 2020
Phase:
Study type: Observational

A multi-center retrospective chart review of short-term outcomes associated with robotic-assisted cholecystectomies performed during regular hours and after-hours.

NCT ID: NCT04300985 Completed - Cholecystectomy Clinical Trials

Magnesium Sulfate Versus Dexmedetomidine on Anesthesia Awakening.

Start date: October 1, 2021
Phase: Phase 3
Study type: Interventional

Magnesium sulfate (MS) and dexmedetomidine have already demonstrated the ability to reduce intra and postoperative consumption of anesthetics and analgesics, among others advantages, such as blood pressure control and intraoperative bleeding. The MS has also been shown to be useful in pre-eclampsia and eclampsia control, pulmonary hypertension, asthma, cardiac arrhythmias and pheochromocytoma). Despite these advantages in the use of these important adjuncts, there is a concern about the quality and awakening time of the patients who use them. The purpose of this trial is to compare the time and quality of awakening in patients submitted to general anesthesia and receiving MS or dexmedetomidine as adjuncts in the intraoperative analgesia. The main objective of this trial is to compare the quality and the awakening time in patients receiving MS or dexmedetomidine. The secondary objective is the comparison of postoperative analgesia in the postoperative hospitalization period. Hypothesis: Our hypothesis is that patients present a faster awakening when receive MS as an analgesic adjunct, when compared to patients who receive dexmedetomidine. Drawing: this is a prospective, controlled, covert trial with random distribution for noninferiority trialing.

NCT ID: NCT04270357 Completed - General Surgery Clinical Trials

Surgical Practices in Algeria : the Cholecystectomy

Start date: November 1, 2016
Phase:
Study type: Observational

An anonymous national survey involving all practicing Algerian surgeons was conducted. At the end of the survey, all data were captured and processed using the SPSS v20 software; χ 2 tests were used to compare different groups of surgeons.

NCT ID: NCT04089592 Completed - Cholecystectomy Clinical Trials

Comparison Of Dexmedetomidine and Fentanyl In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy.

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

Compare effects of intravenous dexmedetomidine and fentanyl in attenuation of intubation response in a patient undergoing laparoscopic cholecystectomy. Compare the effects of intravenous dexmedetomidine and fentanyl in sedation, perioperative complications, and recovery in these patients. Dexmedetomidine is comparatively a newer drug in countries like Pakistan. There is no research work available at the national level and scarcity of data at an international level with inconclusive outcomes. Our participation in the form of this research will add to scientific literature and step up ahead at the international level. Fentanyl citrate is a narcotic analgesic interacting predominantly with the opioid μ receptor and exerting its principal pharmacological effect on CNS. Its primary action of therapeutic value is analgesia and sedation. It is extensively used for anesthetic and analgesic most often in operating room and ICU.

NCT ID: NCT03577873 Completed - Complication Clinical Trials

RCT on Necessity of Cholecystectomy for Patients After Clearance of Bile Duct Stones

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

To discuss necessity of cholecystectomy for patients with stones in their bile ducts and gallbladders in the absence of absolute operation indications of cholecystectomy after clearance of bile duct stones with ERCP.

NCT ID: NCT03510923 Completed - Cholecystectomy Clinical Trials

Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy

FANCY
Start date: May 1, 2018
Phase:
Study type: Observational

The FANCY study will investigate whether a selective policy of histopathological examination of appendices and gallbladders based on the intraoperative findings of the surgeon is safe and cost-effective.

NCT ID: NCT03437187 Completed - Cholecystectomy Clinical Trials

The Beneficial Effect of Quadratus Lumborum Block After Laparoscopic Cholecystectomy

Start date: January 20, 2018
Phase: N/A
Study type: Interventional

The enhanced recovery after surgery and laparoscopic approach is essential after day-case surgery. The patients want to go home early without pain and nausea, and the hospitals need the post-operative capacity for more patients. Many patients have pains, nausea and vomiting postoperatively. Postoperative pain is an expected but undesirable effect after an operation. The aim of the study is to find out if a bilateral quadratus lumborum block has a beneficial effect after a cholecystectomy.

NCT ID: NCT03402542 Completed - Cholecystectomy Clinical Trials

Eligibility Criteria for Cholecystectomy in Ambulatory Surgery

Start date: December 21, 2017
Phase:
Study type: Observational

Cold laparoscopic cholecystectomy is the gold standard for the management of symptomatic vesicular stones. There is considerable controversy as to whether it should be practiced in outpatient surgery or as part of inpatient surgery, regarding to patient safety. "Minor" surgical procedures, such as anal surgery or simple inguinal hernia interventions, were initially considered eligible for an outpatient procedure. Advances in surgical techniques, anesthesia and early rehabilitation have also made it possible to consider more "heavy" interventions, such as cholecystectomy. The aim of this study is to identify eligible patients for laparoscopic cholecystectomy in outpatient surgery, taking surgical criteria into account.